Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplants

BackgroundThis study assesses the impact of human leukocyte antigen (HLA)-DR mismatch and donor-estimated glomerular filtration rate (eGFR) on outcomes of living donor kidney transplantation (LDKT), which are especially relevant to the availability of multiple donors and paired kidney exchanges.Meth...

Full description

Saved in:
Bibliographic Details
Main Authors: Pooja Budhiraja, Jesse D. Schold, Rocio Lopez, Susana Arrigain, Bruce Kaplan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Nephrology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneph.2024.1518791/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556713893789696
author Pooja Budhiraja
Jesse D. Schold
Jesse D. Schold
Rocio Lopez
Rocio Lopez
Susana Arrigain
Susana Arrigain
Bruce Kaplan
Bruce Kaplan
author_facet Pooja Budhiraja
Jesse D. Schold
Jesse D. Schold
Rocio Lopez
Rocio Lopez
Susana Arrigain
Susana Arrigain
Bruce Kaplan
Bruce Kaplan
author_sort Pooja Budhiraja
collection DOAJ
description BackgroundThis study assesses the impact of human leukocyte antigen (HLA)-DR mismatch and donor-estimated glomerular filtration rate (eGFR) on outcomes of living donor kidney transplantation (LDKT), which are especially relevant to the availability of multiple donors and paired kidney exchanges.MethodsUsing data from the Scientific Registry of Transplant Recipients (SRTR), we retrospectively analyzed graft survival in adult LDKT recipients transplanted between January 2013 and September 2022. Recipients with 0 HLA-DR mismatches were compared to those with 1-2 HLA-DR mismatches. Cox models assessed the association between donor eGFR and graft and patient survival, stratifying by a) HLA-DR mismatches, and b) HLA-DR mismatches and recipient age.ResultsAmong 44,080 recipients, 7,195 had 0 HLA-DR mismatches and 36,885 had 1-2 HLA-DR mismatches. The recipients’ mean age was 49.1 for the 0 HLA-DR mismatch group and 50.4 for the 1-2 HLA-DR mismatch group. The donors’ mean age was 43.1 and 43.8, with an eGFR of 101.0 and 99.9 ml/min, respectively. A higher donor eGFR was associated with better graft survival. Stratified analyses showed higher donor eGFR levels reduced the risk of graft loss in cases with DR mismatch (p < 0.001) but not in cases without HLA-DR mismatch (p = 0.81). This effect was significant for recipients aged 18-39 and over 60. Similar results were observed for patient survival.ConclusionsHigher donor eGFR was associated with lower risks of graft loss and patient death in the HLA-DR mismatch group but not the 0 HLA-DR mismatch group. These results emphasize the importance of considering both HLA-DR matching and donor kidney function, particularly for younger recipients to avoid sensitization for future transplants.
format Article
id doaj-art-4e18fd1e93cc4c0facc10b025e0b27bb
institution Kabale University
issn 2813-0626
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nephrology
spelling doaj-art-4e18fd1e93cc4c0facc10b025e0b27bb2025-01-07T06:42:22ZengFrontiers Media S.A.Frontiers in Nephrology2813-06262025-01-01410.3389/fneph.2024.15187911518791Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplantsPooja Budhiraja0Jesse D. Schold1Jesse D. Schold2Rocio Lopez3Rocio Lopez4Susana Arrigain5Susana Arrigain6Bruce Kaplan7Bruce Kaplan8Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, United StatesDepartment of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United StatesBackgroundThis study assesses the impact of human leukocyte antigen (HLA)-DR mismatch and donor-estimated glomerular filtration rate (eGFR) on outcomes of living donor kidney transplantation (LDKT), which are especially relevant to the availability of multiple donors and paired kidney exchanges.MethodsUsing data from the Scientific Registry of Transplant Recipients (SRTR), we retrospectively analyzed graft survival in adult LDKT recipients transplanted between January 2013 and September 2022. Recipients with 0 HLA-DR mismatches were compared to those with 1-2 HLA-DR mismatches. Cox models assessed the association between donor eGFR and graft and patient survival, stratifying by a) HLA-DR mismatches, and b) HLA-DR mismatches and recipient age.ResultsAmong 44,080 recipients, 7,195 had 0 HLA-DR mismatches and 36,885 had 1-2 HLA-DR mismatches. The recipients’ mean age was 49.1 for the 0 HLA-DR mismatch group and 50.4 for the 1-2 HLA-DR mismatch group. The donors’ mean age was 43.1 and 43.8, with an eGFR of 101.0 and 99.9 ml/min, respectively. A higher donor eGFR was associated with better graft survival. Stratified analyses showed higher donor eGFR levels reduced the risk of graft loss in cases with DR mismatch (p < 0.001) but not in cases without HLA-DR mismatch (p = 0.81). This effect was significant for recipients aged 18-39 and over 60. Similar results were observed for patient survival.ConclusionsHigher donor eGFR was associated with lower risks of graft loss and patient death in the HLA-DR mismatch group but not the 0 HLA-DR mismatch group. These results emphasize the importance of considering both HLA-DR matching and donor kidney function, particularly for younger recipients to avoid sensitization for future transplants.https://www.frontiersin.org/articles/10.3389/fneph.2024.1518791/fullHLA-DRHLA matchingliving donor kidney transplanteGFRgraft survival
spellingShingle Pooja Budhiraja
Jesse D. Schold
Jesse D. Schold
Rocio Lopez
Rocio Lopez
Susana Arrigain
Susana Arrigain
Bruce Kaplan
Bruce Kaplan
Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplants
Frontiers in Nephrology
HLA-DR
HLA matching
living donor kidney transplant
eGFR
graft survival
title Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplants
title_full Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplants
title_fullStr Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplants
title_full_unstemmed Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplants
title_short Evaluating the impact of donor eGFR and HLA-DR mismatch on graft survival in living donor kidney transplants
title_sort evaluating the impact of donor egfr and hla dr mismatch on graft survival in living donor kidney transplants
topic HLA-DR
HLA matching
living donor kidney transplant
eGFR
graft survival
url https://www.frontiersin.org/articles/10.3389/fneph.2024.1518791/full
work_keys_str_mv AT poojabudhiraja evaluatingtheimpactofdonoregfrandhladrmismatchongraftsurvivalinlivingdonorkidneytransplants
AT jessedschold evaluatingtheimpactofdonoregfrandhladrmismatchongraftsurvivalinlivingdonorkidneytransplants
AT jessedschold evaluatingtheimpactofdonoregfrandhladrmismatchongraftsurvivalinlivingdonorkidneytransplants
AT rociolopez evaluatingtheimpactofdonoregfrandhladrmismatchongraftsurvivalinlivingdonorkidneytransplants
AT rociolopez evaluatingtheimpactofdonoregfrandhladrmismatchongraftsurvivalinlivingdonorkidneytransplants
AT susanaarrigain evaluatingtheimpactofdonoregfrandhladrmismatchongraftsurvivalinlivingdonorkidneytransplants
AT susanaarrigain evaluatingtheimpactofdonoregfrandhladrmismatchongraftsurvivalinlivingdonorkidneytransplants
AT brucekaplan evaluatingtheimpactofdonoregfrandhladrmismatchongraftsurvivalinlivingdonorkidneytransplants
AT brucekaplan evaluatingtheimpactofdonoregfrandhladrmismatchongraftsurvivalinlivingdonorkidneytransplants